1
UI - 2790788
AU - Bunin GR; Meadows AT; Emanuel BS; Buckley JD; Woods WG; Hammond GD
TI -
Pre- and postconception factors associated with sporadic heritable and
nonheritable retinoblastoma.
SO - Cancer Res 1989 Oct 15;49(20):5730-5
AD - Children's Hospital, Philadelphia, Pennsylvania.
A matched case-control study of retinoblastoma was conducted by the
Children's Cancer Study Group (CCSG) to investigate the hypotheses that
postconception exposures affect the risk of the nonheritable
(post-zygotic origin) form of this disease and that preconception
exposures affect the risk of the sporadic heritable (prezygotic origin)
form. Eligible cases were those patients with retinoblastoma diagnosed
in 1982-1985 at any of the CCSG member hospitals. Cases were classified
as familial heritable, sporadic heritable, or nonheritable based on
family history, tumor laterality, and cytogenetic analysis. Telephone
interviews of parents of 201 cases and their pair-matched controls
selected by random digit dialing were completed. Analysis of possible
risk factors for the 67 sporadic heritable cases and the 115
nonheritable cases was performed. (The 19 familial cases were excluded).
For the nonheritable group, gestational exposure to X-ray [odds ratio
(OR) = 2.3, P = 0.08] and morning sickness medication (OR = 2.8, P =
0.02) and low maternal educational level (OR = 5.5, P = 0.03) were
associated with increased risk; anemia (OR = 0.3, P = 0.02) and
multivitamin use (OR = 0.4, P = 0.03) during pregnancy and
periconceptional use of barrier contraceptive (OR = 0.1, P = 0.02) or
spermicide (OR = 0.2, P = 0.02) were associated with decreased risk. In
the sporadic heritable group, observations included a negative
association with multivitamins during pregnancy (OR = 0.2, P = 0.02) and
nonsignificant positive associations with preconception gonadal X-ray
(maternal, OR = 2.0, P = 0.30; paternal, OR = 1.8, P = 0.42) and older
parental age (case-control difference 1.0-1.2 years, P = 0.24-0.27).
Many of the associations support study hypotheses, although the
possibility of recall bias and chance findings suggest cautious
interpretation.
2
UI - 9479294
AU - Kiratli H; Bilgic S; Ozerdem U
TI -
Management of massive orbital involvement of intraocular retinoblastoma.
SO - Ophthalmology 1998 Feb;105(2):322-6
AD - Department of Ophthalmology, Hacettepe University, School of Medicine,
Ankara, Turkey.
OBJECTIVE: This study aimed to evaluate various combinations of
therapeutic approaches in an attempt to improve the poor outcome of
advanced cases of orbital involvement of intraocular retinoblastoma.
DESIGN: The study design was a retrospective, uncontrolled descriptive
case series of consecutive patients with massive orbital retinoblastoma
treated and observed at a referral center. PARTICIPANTS: Sixteen
patients with unilateral orbital involvement of intraocular
retinoblastoma were studied. Eight patients had orbital involvement at
initial presentation and eight children presented with orbital tumor
after enucleation for intraocular retinoblastoma. Patients having
microscopic evidence of tumor invasion at surgical section of the optic
nerve and subsequently receiving other forms of treatment were not
included in the study. INTERVENTION: Six patients had orbital
exenteration followed by external beam radiation therapy (4600-6000 cGy
in fractionated doses) and chemotherapy. Five patients received
chemotherapy only. Three patients were treated by exenteration and
chemotherapy, whereas two patients underwent radiation therapy and
chemotherapy. MAIN OUTCOME MEASURES: Tumor regression monitored by
clinical observations and imaging studies and patient survival was
studied. RESULTS: The median follow-up was 22 months (range, 4-168
months). All forms of treatment caused satisfactory local and systemic
tumor regression. Two children achieved a survival of more than 10
years. However, two patients in the exenteration followed by
chemotherapy and radiation therapy group and one who received
chemotherapy only had central nervous system metastases develop and
died. Only one patient was lost to follow-up. CONCLUSION: Highly
individualized aggressive treatment by combining radical surgery,
chemotherapy, and external beam radiation therapy allowed most of the
authors' patients to have longer survival and disease-free intervals
than expected.
3
UI - 11911540
AU - Singh AD; Shields CL; Shields JA
TI -
Lack of response to chemoreduction in presumed well differentiated
retinoblastoma.
SO - J Pediatr Ophthalmol Strabismus 2002 Mar-Apr;39(2):107-9
AD - Oncology Service, Wills Eye Hospital, Thomas Jefferson University,
Philadelphia, Pennsylvania 19107, USA.
4
UI - 12234894
AU - Finger PT; Khoobehi A; Ponce-Contreras MR; Rocca DD; Garcia JP Jr
TI -
Three dimensional ultrasound of retinoblastoma: initial experience.
SO - Br J Ophthalmol 2002 Oct;86(10):1136-8
AD - The New York Eye Cancer Center and New York University School of
Medicine, New York City 10021, USA. pfinger@eyecaner.com
AIM: To use 3D ultrasonography (3DUS) for the diagnosis of
retinoblastoma. METHODS: Five eyes of three children with retinoblastoma
were evaluated using a commercially available computerised 3DUS system.
Interactive sectioning of the stored and reconstructed 3D volumes were
performed. 3DUS and histopathological findings were correlated after
enucleation. RESULTS: 3DUS examination revealed characteristics
consistent with retinoblastoma: endophytic mass, retinal detachment,
intratumoural calcifications, and secondary orbital shadowing. Unlike 2D
imaging, 3DUS allowed for analysis of the acquired and stored volumes.
Rotation and sectioning of this volume allowed the discovery of new
oblique and coronal views. For example, calcium related orbital shadows
were seen as 3D volumes and (coronal) cross sections of the optic nerve
were evaluated for evidence of intraneural invasion by retinoblastoma.
CONCLUSION: This is the first reported series of patients examined with
3DUS imaging for retinoblastoma. This technique allowed for new oblique
and coronal views of the tumour and optic nerve. The ability to
retrospectively analyse the (scanned and stored) ocular volume
facilitated patient care, teaching, tumour-volume analysis, and
telemedicine.
5
UI - 12365923
AU - Puig JJ; Arrondo E; Garcia-Arumi J; Gil JJ; Huguet P; Calatayud M
TI -
Multiple anterior chamber cystic lesions as the first sign of advanced
retinoblastoma.
SO - Arch Ophthalmol 2002 Oct;120(10):1385-8
AD - Hospital Valle de Hebron, Departamento de Oftalmologia, Paseo Valle de
Hebron 119-129, Barcelona 08035, Spain. 29213jpg@comb.es
The above citations and abstracts reflect those newly added to CANCERLIT for the month and topic listed in the title. The citations have been retrieved from CANCERLIT using a predefined search strategy of indexed subject terms. Although the search strategy has been refined as best as possible, citations may appear that are not directly related to the topic, and occasionally relevant references may be omitted.